Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
The APC tumor suppressor inhibits DNA replication by directly binding to DNA via its carboxyl terminus.
Qian J
,
Sarnaik AA
,
Bonney TM
,
Keirsey J
,
Combs KA
,
Steigerwald K
,
Acharya S
,
Behbehani GK
,
Barton MC
,
Lowy AM
,
Groden J
.
???displayArticle.abstract???
The APC tumor suppressor is well known for its ability to regulate Wnt signaling through mediation of beta-catenin levels in the cell. Transient over expression of the tumor suppressor gene APC in colon cancer cells prevents entry into S phase of the cell cycle, a phenotype only partially restored by cotransfection of a transcriptionally active form of beta-catenin. In an attempt to define its transcription-independent tumor suppressor functions, we tested whether APC directly affects DNA replication. A transcriptionally quiescent in vitro DNA replication system, the polymerase chain reaction, DNA binding assays, and transient transfections in colon cancer cell lines were used to determine the effects of APC on DNA replication and the mechanism by which it works. We report that exogenous full-length APC inhibits replication of template DNA through a function that maps to amino acids 2140-2421, a region of the protein commonly lost by somatic or germline mutation. This segment of APC directly interacts with DNA, while mutation of the DNA-binding S(T)PXX motifs within it abolishes DNA binding and reduces inhibition of DNA replication. Phosphorylation of this segment by cyclin-dependent kinases also reduces inhibition of DNA replication. Furthermore, transient transfection of an APC segment encoding amino acids 2140-2421 into a colon cancer cell line with mutant APC prevents cell cycle progression into or through S phase. Our results suggest that APC can negatively regulate cell cycle progression through inhibition of DNA replication by direct interaction with DNA.
Baeg,
The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase.
1995, Pubmed
Baeg,
The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase.
1995,
Pubmed
Blow,
Initiation of DNA replication in nuclei and purified DNA by a cell-free extract of Xenopus eggs.
1986,
Pubmed
,
Xenbase
Brocardo,
Redefining the subcellular location and transport of APC: new insights using a panel of antibodies.
2005,
Pubmed
Carpenter,
Role for a Xenopus Orc2-related protein in controlling DNA replication.
1996,
Pubmed
,
Xenbase
Carson,
Isoforms of the APC tumor suppressor and their ability to inhibit cell growth and tumorigenicity.
2004,
Pubmed
Churchill,
'SPKK' motifs prefer to bind to DNA at A/T-rich sites.
1989,
Pubmed
Coleman,
The Xenopus Cdc6 protein is essential for the initiation of a single round of DNA replication in cell-free extracts.
1996,
Pubmed
,
Xenbase
Crawford,
The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.
1999,
Pubmed
Crowe,
In vitro reconstitution of nuclei for replication and transcription.
1999,
Pubmed
,
Xenbase
Deka,
The APC protein binds to A/T rich DNA sequences.
1999,
Pubmed
Deka,
A domain within the tumor suppressor protein APC shows very similar biochemical properties as the microtubule-associated protein tau.
1998,
Pubmed
Dikovskaya,
The adenomatous polyposis coli protein is required for the formation of robust spindles formed in CSF Xenopus extracts.
2004,
Pubmed
,
Xenbase
Goss,
Biology of the adenomatous polyposis coli tumor suppressor.
2000,
Pubmed
Hamada,
The APC tumor suppressor binds to C-terminal binding protein to divert nuclear beta-catenin from TCF.
2004,
Pubmed
He,
Identification of c-MYC as a target of the APC pathway.
1998,
Pubmed
Heinen,
The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway.
2002,
Pubmed
Henderson,
Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover.
2000,
Pubmed
Ishidate,
The APC-hDLG complex negatively regulates cell cycle progression from the G0/G1 to S phase.
2000,
Pubmed
Kaplan,
A role for the Adenomatous Polyposis Coli protein in chromosome segregation.
2001,
Pubmed
Kinzler,
Lessons from hereditary colorectal cancer.
1996,
Pubmed
Li,
Human protein tau represses DNA replication in vitro.
2005,
Pubmed
Liu,
Siah-1 mediates a novel beta-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein.
2001,
Pubmed
,
Xenbase
Matsumine,
Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein.
1996,
Pubmed
McGarry,
Geminin, an inhibitor of DNA replication, is degraded during mitosis.
1998,
Pubmed
,
Xenbase
Mimori-Kiyosue,
The dynamic behavior of the APC-binding protein EB1 on the distal ends of microtubules.
2000,
Pubmed
,
Xenbase
Mogensen,
The adenomatous polyposis coli protein unambiguously localizes to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells.
2002,
Pubmed
Morrison,
EB1, a protein which interacts with the APC tumour suppressor, is associated with the microtubule cytoskeleton throughout the cell cycle.
1998,
Pubmed
Munemitsu,
The APC gene product associates with microtubules in vivo and promotes their assembly in vitro.
1994,
Pubmed
Neufeld,
Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm.
2000,
Pubmed
Neufeld,
Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein.
1997,
Pubmed
Newmeyer,
Egg extracts for nuclear import and nuclear assembly reactions.
1991,
Pubmed
,
Xenbase
Newport,
Nuclear reconstitution in vitro: stages of assembly around protein-free DNA.
1987,
Pubmed
,
Xenbase
Näthke,
The adenomatous polyposis coli tumor suppressor protein localizes to plasma membrane sites involved in active cell migration.
1996,
Pubmed
Qian,
Caspase cleavage of the APC tumor suppressor and release of an amino-terminal domain is required for the transcription-independent function of APC in apoptosis.
2007,
Pubmed
Rosin-Arbesfeld,
The APC tumour suppressor has a nuclear export function.
2000,
Pubmed
Sierra,
The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes.
2006,
Pubmed
Smith,
Wild-type but not mutant APC associates with the microtubule cytoskeleton.
1994,
Pubmed
Su,
APC binds to the novel protein EB1.
1995,
Pubmed
Suzuki,
SPKK, a new nucleic acid-binding unit of protein found in histone.
1989,
Pubmed
Tetsu,
Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.
1999,
Pubmed
Tirnauer,
EB1 proteins regulate microtubule dynamics, cell polarity, and chromosome stability.
2000,
Pubmed
Trzepacz,
Phosphorylation of the tumor suppressor adenomatous polyposis coli (APC) by the cyclin-dependent kinase p34.
1997,
Pubmed
Zhang,
Phosphorylation near nuclear localization signal regulates nuclear import of adenomatous polyposis coli protein.
2000,
Pubmed
Zhang,
Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.
2001,
Pubmed